(Q51861103)

English

Five commercially available insulin-like growth factor I (IGF-I) assays in comparison to the former Nichols Advantage IGF-I in a growth hormone treated population.

scientific article published in January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19055455

Five commercially available insulin-like growth factor I (IGF-I) assays in comparison to the former Nichols Advantage IGF-I in a growth hormone treated population. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19055455

1 reference

based on heuristic

inferred from title

6

object named as

Henry Völzke

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19055455

author name string

Alexander Krebs

1

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19055455

Henri Wallaschofski

2

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19055455

Elisabeth Spilcke-Liss

3

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19055455

Thomas Kohlmann

4

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19055455

Georg Brabant

5

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19055455

Matthias Nauck

7

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19055455

publication date

1 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19055455

Clinical Chemistry and Laboratory Medicine

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19055455

46

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19055455

12

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19055455

1776-1783

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19055455

Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.349

21 January 2018

Insulin-like growth factors and their binding proteins: biological actions

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.349

21 January 2018

Insulin-like growth factor-I: marker for diagnosis of acromegaly and monitoring the efficacy of treatment

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.349

21 January 2018

The diagnosis of growth hormone deficiency in children and adults

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.349

21 January 2018

Reference values for insulin-like growth factor-binding protein-3 (IGFBP-3) and the ratio of insulin-like growth factor-I to IGFBP-3 throughout childhood and adolescence.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.349

21 January 2018

Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.349

21 January 2018

Reference ranges of serum IGF-1 and IGFBP-3 levels in a general adult population: results of the Study of Health in Pomerania (SHIP).

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.349

21 January 2018

Reference Levels of Insulin-Like Growth Factor I in the Serum of Healthy Adults: Comparison of Four Immunoassays

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.349

21 January 2018

Effects of growth hormone treatment on B-type natriuretic peptide as a marker of heart failure in adults with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.349

21 January 2018

Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3).

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.349

21 January 2018

Variation in GH and IGF-I assays limits the applicability of international consensus criteria to local practice.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.349

21 January 2018

How much insulin-like growth factor I (IGF-I) circulates? Impact of standardization on IGF-I assay accuracy

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.349

21 January 2018

Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.349

21 January 2018

IGF-I assays: current assay methodologies and their limitations

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.349

21 January 2018

Identifiers

10.1515/CCLM.2008.349

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19055455

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 April 2018

http://europepmc.org/abstract/MED/19055455

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51861103&oldid=2143566112"